AT&T won approval Tuesday of its $85 billion bid for Time Warner, a decision that could pave the way for more mega-deals in the media industry.
A U.S. judge ruled the Justice Department did not sufficiently show that a tie-up would stifle competition or harm consumers. He also tried to dissuade the government from appealing his decision.
The merger of the two companies, announced in October 2016, was closely watched by other media and telecom companies with ambitions to cross over.
Internet providers and cable distributors are looking for new revenue sources to compete with streaming content companies such as Netflix and Amazon.
But the government has been skeptical of the consolidation of content and delivery. The Justice Department sued to block AT&T's deal last November, citing concerns over the telecom company owning both DirecTV and Time Warner.
Tuesday's ruling in favor of AT&T could preclude similar arguments to block mergers down the road.
The cable TV giant Comcast said earlier this week it would submit an all-cash bid as early as Wednesday to buy assets from 21st Century Fox if the AT&T acquisition was approved.
Comcast's bid for Fox could upend Disney's offer, and send that company looking for another target.
Shares of Comcast, Disney, and AT&T were all down after the judge's ruling. Fox and Time Warner stock were rising.
An AT&T spokesman said the company is "gratified" by the decision. The deal is expected to close by June 20.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
